Literature DB >> 3495577

Transcriptional regulation of the human prointerleukin 1 beta gene.

M J Fenton, B D Clark, K L Collins, A C Webb, A Rich, P E Auron.   

Abstract

Interleukin 1 (IL 1) is a protein produced by monocytes in response to certain antigens which produces a wide variety of cellular responses in various tissues. We have studied the regulation of the human proIL-1 beta gene in THP-1 human monocytic leukemia cells. Lipopolysaccharide (LPS) induction of this gene results in an immediate and transient increase of message that rapidly falls to a low, but constant, level within 6 hr. This decrease results from a specific repression of transcription by 2 hr after stimulation. Cycloheximide inhibition of new protein synthesis causes a superinduction of IL 1 message, but does not alter the initial kinetics of message production. This presumably delays the synthesis of a labile transcriptional repressor protein and implies that the proIL-1 beta gene is under the control of both a transcriptional activator and a newly synthesized transcriptional repressor. The transient increase in mRNA production and the sustained low-level synthesis beyond the initial transient response suggest that the IL 1 protein itself may act intracellularly in a manner analogous to that described for several proto-oncogenes and cellular competence factors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495577

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

Review 1.  Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.

Authors:  Kristina Ludigs; Valeriy Parfenov; Renaud A Du Pasquier; Greta Guarda
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

2.  Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells.

Authors:  R A Barthelson; F H Valone
Journal:  Lipids       Date:  1991-03       Impact factor: 1.880

Review 3.  The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation.

Authors:  J Auwerx
Journal:  Experientia       Date:  1991-01-15

4.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Dietary marine lipids suppress continuous expression of interleukin-1 beta gene transcription.

Authors:  D R Robinson; M Urakaze; R Huang; H Taki; E Sugiyama; C T Knoell; L Xu; E T Yeh; P E Auron
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

6.  Release of interleukin 1 inhibitory activity (contra-IL-1) by human monocyte-derived macrophages infected with human immunodeficiency virus in vitro and in vivo.

Authors:  R M Locksley; S Crowe; M D Sadick; F P Heinzel; K D Gardner; M S McGrath; J Mills
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 7.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

8.  Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.

Authors:  D W Kimberlin; S A Willis; G H McCracken; P D Nisen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

9.  Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

Authors:  L C Miller; S Isa; E Vannier; K Georgilis; A C Steere; C A Dinarello
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.

Authors:  Philip T Liu; Mirjam Schenk; Valencia P Walker; Paul W Dempsey; Melissa Kanchanapoomi; Matthew Wheelwright; Aria Vazirnia; Xiaoran Zhang; Andreas Steinmeyer; Ulrich Zügel; Bruce W Hollis; Genhong Cheng; Robert L Modlin
Journal:  PLoS One       Date:  2009-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.